A systematic review and meta-analysis comparing prandial insulin analogs and native human insulin with respect to sugar control of type 1 diabetes mellitus revealed that prandial insulin analogs are superior to native human insulin in terms of episodes of total hypoglycemic events, postprandial glucose, and HbA1c outcomes [42,43]. This evidence concerns the gene INS and diabetes mellitus.